diarrhea after stopping tirzepatide 🚨 What actually happens when patients stop GLP-1 medications? A new real-world study looked at nearly 8,000 adults with obesity treated with semaglutide or tirzepatide—and the results challenge how we think about Diarrhea x3 days after dosage

Cardiovascular Effects Melanocortin receptors are expressed in cardiovascular tissue

A total of 23 patients (16.7%) reported adverse events, including insomnia, shivering, headaches, and nausea

Biohaven Biohaven is evaluating its myostatin targeting drug, taldefgrobep alfa, in an early-stage obesity trial

This slow increase allows your body to adjust to the medication while minimizing common side effects like nausea

Dysesthesia In a pool of Study 1 and 2, dysesthesia occurred more frequently among patients receiving ZEPBOUND (5 mg 0.2%, 10 mg 0.2%, 15 mg 0.4%) than placebo (0.1%)

its about embracing a holistic approach to health